BSE: 524470 - Syncom Formulations (India) Limited

Rentabilidad a seis meses: -32.56%
Rendimiento de dividendos: 0.00%

Calendario de promoción Syncom Formulations (India) Limited


Acerca de la empresa Syncom Formulations (India) Limited

Syncom Formulations (India) Limited, a pharmaceutical company, discovers, develops, manufactures, and markets a range of healthcare products in India. The company offers approximately 300 pharmaceutical formulations in various dosage forms, such as tablets, capsules, liquids orals, liquid vials and ampoules injections, dry vial injections, dry syrups, ointments, inhalers, and herbals.

más detalles
Its products comprise generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite. The company also offers histamines, homeostatic, hypoglycemic, hypolipidaemics, local anesthetics, multivitamins and nutritional supplements, sedative anticonvulsants, stimulants, and sympathomimetic products, as well as products used in the treatment of gout. In addition, it exports active pharmaceutical ingredients and surgical products; agro and confectionary products comprising rice, wheat flour, chickpeas, soy doc, biscuits, and candies; and fasteners, steel bars, roofing sheets, and jute bags, as well as metal scrap. Additionally, the company rents properties. Syncom Formulations (India) Limited was founded in 1985 and is based in Indore, India.

Industry Biotechnology
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0
Дивиденд ао 0.03
Сайт http://www.syncomformulations.com
Цена ао 15.61
Cambio de precio por día: +2.02% (15.33)
Cambio de precio por semana.: -2.25% (16)
Cambio de precio por mes: -10.98% (17.57)
Cambio de precio en 3 meses.: -27.29% (21.51)
Cambio de precio en seis meses: -32.56% (23.19)
Cambio de precio por año: +12.52% (13.9)
Cambio de precio en 3 años.: -7.84% (16.97)
Cambio de precio en 5 años.: +2 200% (0.68)
Cambio de precio desde principios de año.: -23.37% (20.41)

Subestimación

Nombre Significado Calificación
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Eficiencia

Nombre Significado Calificación
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0.8571 8.57
Total: 3.46

Deber

Nombre Significado Calificación
Debt/EBITDA 0 10
Total: 10

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 20.07 4
Rentabilidad Ebitda, % 0 0
Rentabilidad EPS, % 50.26 7
Total: 4

Supervisor Título profesional Pago año de nacimiento
Mr. Kedarmal Shankarlal Bankda Whole-Time Director & Exec. Chairman 1952 (73 año)
Mr. Vijay Shankarlal Bankda MD and Exec. & Non Independent Director 1958 (67 años)
Mr. Ankit Kedarmal Bankda Chief Financial Officer 1987 (38 años)
Mr. Shubham Dubey C.S. Company Sec. & Compliance Officer
Mr. Rakesh Ch. Srivastava VP of Marketing 1962 (63 año)
Ms. Rinki Ankit Bankda Whole Time Director 1987 (38 años)
Suresh B. Paithankar VP of International Marketing 1970 (55 años)

DIRECCIÓN: India, Indore, 207 Saket Nagar - abrir en mapas de google, abrir mapas de Yandex
Sitio web: http://www.syncomformulations.com